Like I've tried to tell you before (but you wouldn't listen because your
knowledge of pharmacology is next to non-existent), normal dose naltrexone
is very different from low dose naltrexone. The effects are almost
opposite. Posting links that are not related to the subject in the post
is not productive. If you have nothing to say, you don't have to say
anything at all.

There are many clinical studies about LDN underway, including several for
MS and autism, one for HIV/AIDS, one for Crohn's and one for fibromyalgia.
Apparently one of the main LDN researchers, Ian S. Zagon (a distinguished
professor at the Penn State university) is also currently conducting trials
of LDN for pancreatic cancer and squamous cell carcinoma of the head and
neck, even though they are not listed on clinicaltrials.gov.

My list of dozens of LDN related references (most of them relevant to
cancer) is at http://ldn.gehennom.org/tiede.html - though it is a bit out
of date, I have a few more recent references to add there.